MedPath

Validation Freestyle continuous registration of glucose for the purpose of safe and correct use in the Netherlands

Conditions
diabetes mellitusglucose measurementsvalidation of glucose measurement technique
Registration Number
NL-OMON28417
Lead Sponsor
Drs M.J.Fokkertdepartment of Clinical ChemistryIsala ClinicsP.O.Box 10,4008000GK Zwollem.j.fokkert@isala.nl
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Other
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

10 non-DM, 10 T1DM, 10 T2DM in a stable situation

Able to undergo the required controls and to fill in the questionnaires proposed

Exclusion Criteria

Unable to understand the study information or the Dutch language

A condition that makes the health situation unstable or which results in the short term to serious
deterioration or death.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Validate the Abbott Freestyle-Libre glucose measurement technique used on various insertion sites, by comparing its outcomes with another continuous glucose monitoring (CGM) technique and laboratory testing as the golden standard for glucose measurement.
Secondary Outcome Measures
NameTimeMethod
1. Comparing the use of the Freestyle Libre between insertion in the upper arm and abdominal insertion (currently the Freestyle Libre is only tested after insertion into the upper arm, comparative data on other places where this device can be inserted are missing) 2. Study the glucose values after eating a meal using the Freestyle Libre and venous measurements (meal clamp technique) 3. Study the influence of the use of paracetamol and vitamin C on the reliability of the Freestyle libre results.
© Copyright 2025. All Rights Reserved by MedPath